Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Archive
Date
Headline/Title
24 December 2014
2014 Anti-Retroviral Tender Results
10 December 2014
Results of AGM
10 December 2014
Changes to the Board
05 December 2014
Directors Dealings
11 November 2014
Clarification in Respect of Form of Proxy
31 October 2014
Aspen Holdings Acquires Stake In Infant Milk Formula Production Facility In New Zealand
30 October 2014
No change statement and notice of annual general meeting
23 October 2014
Dealings in securities by directors company secretary and directors of a major subsidiary
20 October 2014
Aspen to acquire license rights
09 October 2014
Aspen to enter strategic collaboration with GlaxoSmithKline in Japan
26 September 2014
Further announcement regarding the disposal of rights to commercialise fondaparinux products in the US
10 September 2014
Aspen final results 30 June 2014
08 September 2014
Year-end Results and Results Presentation
03 September 2014
Pre-Closed Period Conference Call
29 August 2014
Trading Statement
30 June 2014
Appointment of Maureen Manyama-Matome as member of the Audit & Risk Committee
30 June 2014
Response to media reports following pre-closed period conference call
27 June 2014
Dealings by a Director of a Major Subsidiary
04 June 2014
Dealings by a Director of a Major Subsidiary
20 May 2014
Directors Dealings
19 May 2014
Appointment of an Independent Non-Executive Director
31 March 2014
Dealing in securities by a director of a major subsidiary
24 March 2014
Directors Dealings
19 March 2014
Dealing in securities by a director of a major subsidiary
06 March 2014
Aspen interim result December 2013
21 February 2014
Voluntary Trading Statement
Powered by
ProfileData